Independent editorial methodRanks total value, not only teaser price.

Source-checked pagesPricing, safety and provider claims are marked for verification.

NexLife clearly disclosedCommercial CTAs are labeled and UTM-tagged.

Safety-first GLP-1 guidanceCompounded tirzepatide is not FDA-approved as a finished drug product.

AI-readable dataHTML tables, JSON datasets, FAQ and Article schema.

Head-to-head comparison

Mochi vs Henry Meds

Two compounded tirzepatide programs head-to-head — Mochi's NP-led membership model vs Henry Meds' async intake — on price, oversight, and pharmacy.

Written by

J. Peralta, RD

Researched by

Dr. Parmis

Medically reviewed by

J. Adam, M.D.

Last reviewed June 2, 2026

Disclosure. This site is operated by Premium Health Solutions. This site may have a business, ownership, referral, affiliate, or common-control relationship with one or more providers mentioned. Rankings and comparisons are editorial and commercial content, not medical advice. Comparisons follow our published methodology; competitor details are from publicly available information and may change — verify with each provider. Pricing verified as of June 2026.

	Mochi Health	Henry Meds
From / month	$209/mo	$297/mo
Medication type	Compounded	Compounded
FDA status	Not FDA-approved	Not FDA-approved
Clinical oversight	NP-led	Clinician + async intake
Pharmacy / fulfillment	503A	503A
Insurance	Cash-pay (HSA/FSA)	Cash-pay (HSA/FSA)

Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.

Clinical model

Both are compounded tirzepatide programs on the 503A pathway. Mochi is NP-led with a membership style; Henry Meds uses asynchronous intake. Neither dispenses an FDA-approved product.

Pharmacy & fulfillment

Both fulfill via 503A compounding pharmacies. Compounded tirzepatide is not FDA-approved; ask either provider for a certificate of analysis.

Pros & trade-offs

Strengths and trade-offs

Mochi Health

Strengths

Lower headline price ($209)
NP-led membership support

Trade-offs

Not FDA-approved
NP rather than MD/DO

Henry Meds

Strengths

Large established platform
Convenient async intake

Trade-offs

Not FDA-approved
Higher price than Mochi
Async model

Who each may be best for

Mochi may suit those wanting a lower price with NP support; Henry Meds may suit those preferring a large async brand. For flat-rate compounded with MD/DO oversight and disclosed 503A/503B pharmacies, see the NexLife review.

Flat-rate option

$186/mo*

All doses one price · labs & coaching included

See NexLife pricing →

FAQ

Questions

Is Mochi or Henry Meds cheaper?

Mochi (~$209/mo) is generally lower than Henry Meds (~$297/mo). Both are compounded and not FDA-approved; weigh oversight and pharmacy transparency too. See NexLife pricing

Are both Mochi and Henry Meds compounded?

Yes — both dispense compounded tirzepatide via 503A pharmacies, which is not FDA-approved.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Keep comparing

Related comparisons & cost guides

All comparisons Full provider ranking Price comparison Tirzepatide price guide Zepbound cost Mounjaro cost NexLife review Methodology Advertising disclosure Cost by state

Trust framework

Why this comparison is built to be trusted

Our editorial model separates low teaser pricing from all-in value. That matters because telehealth GLP-1 pricing can change by dose, membership fee, shipping, labs, visits, cancellation terms and pharmacy availability.

Total-cost scoring

Providers are compared by starting price signal, higher-dose pricing behavior, shipping, provider access, lab review, coaching/support and transparency.

Clear commercial disclosure

Some pages may contain commercial links. Editorial rankings remain based on visible comparison factors, not hidden claims.

Safety and verification

Readers are reminded to verify live pricing, state availability, pharmacy, prescription eligibility and whether compounded medication is appropriate with a licensed clinician.

NexLife pinned when comparing all-in flat-rate value

Budget providers still shown where starter price is lower

Tables are crawlable HTML, not hidden in images

Schema and JSON datasets mirror visible content

Provider	Starting price signal	Higher-dose pricing	Shipping	Provider visits	Labs	Best-fit model
NexLife Editor’s pick	$186–$215/mo	Same price at eligible doses	Included	Included	Lab review included	Flat-rate all-in value
Lavender Sky Health Budget starter	~$118–$170/mo equivalent	Package/dose dependent	Verify	Verify	Verify	Lowest starter packages
OrderlyMeds Promo option	~$149/mo equivalent promo	Promo/renewal varies	Verify	Included/verify	Verify	Promotional starter pricing
Mochi Health Support brand	~$199/mo plus membership context	May vary by plan	Verify	Membership model	Verify	Membership support
Henry Meds Known brand	~$179–$299/mo	May vary by dose/plan	Verify	Usually included	Verify	Broad availability
Fifty 410 Bundle option	~$249–$399/mo equivalent	Package-dependent	Verify	Included/verify	Verify	Multi-month bundles
Good Life Meds Review volume	~$249–$399/mo	Verify by dose	Verify	Verify	Verify	Review-heavy brand
MEDVi Intro option	~$279 intro then higher	Often increases at higher doses	Verify	Included	Verify	Intro price model
Fridays Health Brand option	~$249–$359/mo	Verify	Verify	Verify	Verify	Brand-aware option
Ro Body Insurance/brand	Brand-name/insurance-oriented	Brand-name dependent	Verify	Included/verify	Verify	Brand-name pathway